| Line Item | 2024-09-30 | Y/Y |
|---|---|---|
| Revenue | $15.4M | -3.3% |
| Cost of Revenue | $4.9M | -1.8% |
| Gross Profit | $10.4M | -4.0% |
| R&D Expense | $4.2M | +13.1% |
| SG&A Expense | $3.3M | +3.4% |
| Operating Income | -$2.0M | +79.6% |
| Pre-tax Income | -$2.0M | +79.0% |
| Income Tax | -$43K | +54.3% |
| Net Income | -$2.0M |
| Line Item | 2024-09-30 | Y/Y |
|---|---|---|
| Cash & Equivalents | $1.4M | -41.5% |
| Accounts Receivable | $1.3M | +28.3% |
| Current Assets | $2.9M | -19.5% |
| Total Assets | $15.6M | -11.5% |
| Current Liabilities | $4.7M | -0.4% |
| Long-term Debt | $526K | -25.1% |
| Total Liabilities | $5.6M | -9.3% |
| Line Item | 2024-09-30 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$765K | -376.2% |
| Capital Expenditures | $29K | +16.0% |
| Financing Cash Flow | -$209K | +67.8% |
| Free Cash Flow | -$794K | -415.1% |
| +79.2% |
| EPS (Basic) | -$0.19 | +79.1% |
| EPS (Diluted) | -$0.19 | +79.1% |
| Stockholders' Equity |
| $10.0M |
| -12.7% |